A first time report on the coocurrence of sarcoidosis and ALK(−) CD30(+) anaplastic large cell lymphoma that is highly responsive to brentuximab vedotin treatment
Journal of Oncology Pharmacy Practice, cilt.25, sa.7, ss.1801-1805, 2019 (SCI-Expanded, Scopus)
- Yayın Türü: Makale / Tam Makale
- Cilt numarası: 25 Sayı: 7
- Basım Tarihi: 2019
- Doi Numarası: 10.1177/1078155219837331
- Dergi Adı: Journal of Oncology Pharmacy Practice
- Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
- Sayfa Sayıları: ss.1801-1805
- Anahtar Kelimeler: Sarcoidosis, ALK(-) CD30(+) anaplastic large cell lymphoma, brentuximab vedotin treatment
- Sağlık Bilimleri Üniversitesi Adresli: Evet
Özet
Sarcoidosis is known to be associated with higher incidence of solid tumors and hematological malignancies. ALK(−) CD30(+) anaplastic large cell lymphoma is a type of non-Hodgkin lymphoma showing poor prognosis, and seldom co-occurs with sarcoidosis. As this rare and highly mortal disease did not respond to classical chemotherapies and showed remission with brentuxumab vedontin treatment, we are presenting our first case reported from Turkey hoping to contribute to the literature.